Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Journal of thrombosis and haemostasis, 2020-02, Vol.18 (2), p.411 [Peer Reviewed Journal]2019 International Society on Thrombosis and Haemostasis. ;EISSN: 1538-7836 ;DOI: 10.1111/jth.14662 ;PMID: 31630479
Digital Resources/Online E-Resources